• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

OPEN LETTER: INCREASING THE EARLY DIAGNOSIS OF LUNG CANCER IN EUROPE: AN ESSENTIAL MILESTONE TO TACKLE THE BIGGEST CANCER KILLER

Dear MEPs, The European Respiratory Society (ERS), together with the undersigned 27 organisations, urges you to take into account the […]

IASCL LANGUAGE GUIDE

The International Association for the Study of Lung Cancer released its first-ever Language Guide to promote best practices in all […]

LUCE WEBINAR: STRENGHTENING THE LUNG CANCER PATIENT VOICE IN HEALTH POLICY AND REGULATORY DECISION

As part of its Educational & Capacity Building Programme, Lung Cancer Europe (LuCE) ran an introductory session on Strengthening the Lung Cancer Patient Voice […]

INVESTING IN THE FUTURE: IMPROVING CANCER BIOMARKER TESTING AND CANCER DIAGNOSIS FOR SUSTAINABLE HEALTHCARE

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by […]

LIVING WITH LUNG CANCER: SURVIVORSHIP AND QUALITY OF LIFE – SURVEY FOR PATIENTS AND CAREGIVERS

Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such […]

LUCE WEBINAR: CURRENT RESEARCH LINES IN LUNG CANCER

Lung Cancer Europe (LuCE) held a webinar on current research lines in lung cancer. The webinar was given by Professor Simon […]


Privacy policy
Terms & Conditions

© 2025 Lung Cancer Europe – All Rights Reserved

Website Under Construction

We are currently rebuilding our website, and look forward to its launch later in 2026.

Until then, this website is not being updated. Feel free to continue browsing, or visit our news site for the latest updates.